Acceleration of mobile health for monitoring post-transplant in the COVID-19 era: Applications for pediatric settings.
Acceleration of mobile health for monitoring post-transplant in the COVID-19 era: Applications for pediatric settings.
复制标题
加速 COVID-19 时代监测移植后的移动健康：儿科环境中的应用。
DOI：
10.1111/petr.14152
复制
发表时间：
2022
影响因子：
1.3
通讯作者：
Annunziato,RachelA
中科院分区：
文献类型：
--
作者：
Campagna,BiancaR;Tutino,Rebecca;Stevanovic,Kristina;Flood,Julia;Halevi,Gali;Shemesh,Eyal;Annunziato,RachelA
背景自COVID-19大流行开始以及随后的封锁以来，远程医疗干预措施在普通人群和移植受者中的使用迅速增加。在儿科移植受者中，这最常见的形式是在移动的设备或移动健康上进行干预，例如通过视频聊天或电话进行远程访问，基于电话的监控和移动的应用程序。远程医疗干预措施可以提供机会，提供护理，最大限度地减少了许多障碍的人care.MethodsThe本审查遵循的PRISMA准则。截至2020年10月的来源最初是通过PsycInfo®和PubMed®的搜索确定的。ResultsWe确定了10篇报告成人干预研究结果的论文和5项基于儿科的研究。8篇成人出版物来自相同的两项试验;在儿科亚组中，有2篇论文属于这种情况。已经着眼于移动健康干预的研究发现，在短期内可接受率高，但有一个普遍缺乏长期使用的数据。ConclusionsThe文献周围的儿科试验，特别是稀疏的所有结果参考干预措施，在早期发展阶段，从现场测试到小型可行性试验。缺乏研究强调了需要一个多中心RCT，利用药物依从性和其他结局变量的强大措施，在远程医疗干预措施完全被接受之前进行长期随访。
BackgroundSince the start of the COVID‐19 pandemic and consequent lockdowns, the use of telehealth interventions has rapidly increased both in the general population and among transplant recipients. Among pediatric transplant recipients, this most frequently takes the form of interventions on mobile devices, or mHealth, such as remote visits via video chat or phone, phone‐based monitoring, and mobile apps. Telehealth interventions may offer the opportunity to provide care that minimizes many of the barriers of in‐person care.MethodsThe present review followed the PRISMA guidelines. Sources up until October 2020 were initially identified through searches of PsycInfo®and PubMed®.ResultsWe identified ten papers that reported findings from adult interventions and five studies based in pediatrics. Eight of the adult publications stemmed from the same two trials; within the pediatric subset, this was the case for two papers. Studies that have looked at mHealth interventions have found high acceptability rates over the short run, but there is a general lack of data on long‐term use.ConclusionsThe literature surrounding pediatric trials specifically is sparse with all findings referencing interventions that are in early stages of development, ranging from field tests to small feasibility trials. The lack of research highlights the need for a multi‐center RCT that utilizes robust measures of medication adherence and other outcome variables, with longer‐term follow‐up before telehealth interventions should be fully embraced.